Drug copay coupons decrease use of lower-cost generic and therapeutic alternatives

09/11/2013 | Pharmalot

The use of drug copay coupons has increased by nearly 20% in the past year, data from Crossix Solutions show. Although some patient groups back drugmakers' claims that coupons increase access to crucial drugs, research published in The New England Journal of Medicine found lower-cost, FDA-approved therapeutic equivalents existed for 31 of 374 brand-name drugs offering coupons, and a lower-cost generic alternative existed for 200 of the other 343 drugs.

View Full Article in:

Pharmalot